Geopolitical risk in pharmaceutical supply chains in 2026

AI Summary

Pharmaceutical supply chains are projected to face increased geopolitical risks by 2026, potentially affecting market continuity and compliance. These risks could ultimately impact drug availability and pricing, making it crucial for stakeholders in the industry to prepare.

Pharmaceutical companies face increased risks of continuity loss, delayed market access, and compliance breaches – significantly impacting ...